Cellectis
VerifiedDeveloping allogeneic CAR-T cells.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$148m (Public information from Jul 2024)
Share price
€1.79 ZVAA.F
Company register number 428859052
Paris Île-de-France (HQ)
Deals in current and previous year:
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 387 % | - | (74 %) | 23 % | 28 % | 186 % | 22 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (116 %) | (116 %) | (468 %) | (177 %) | (204 %) | (37 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (110 %) | (110 %) | (554 %) | (323 %) | (254 %) | (90 %) | (10 %) |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 118 % | 118 % | 509 % | - | - | - | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | $140m | Post IPO Equity | |
| Total Funding | 000k | ||
Related Content
Recent News about Cellectis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Cellectis
Edit
ACQUISITION by Cellectis Sep 2011